Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs
GeekWire
DECEMBER 27, 2022
Sonoma chief technology officer Heidi Hagen. Cell therapy startup Sonoma Biotherapeutics netted a $265 million Series B round last year and has not made any operational changes “directly related to external economic conditions,” said chief technology officer Heidi Hagen. Sonoma Photo).
Let's personalize your content